미만성대세포B림프종에서 복합약제내성단백질 P-glycoprotein의 발현 및 세포자멸사와의 상관관계연구
Expression of P-glycoprotein and Apoptosis in Diffuse Large B-cell Lymphoma
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : Diffuse large B-cell lymphoma (DLBCL) is the most common type of malignant lymphoma which responds well to conventional chemotherapy. However, quite a few patients have a recurrence with more aggressive forms after completion of therapy. Multidrug resistance proteins (MRP) are related to this process in several ways such as cell cycle alteration and modulation of apoptosis. Methods : We investigated the expression of P-glycoprotein (Gp), one of the well-known MRP, as well as apoptosis associated proteins in DLBCL. Immunohistochemical staining for Gp, p53, Bcl-2, Ki-67, active caspase 3 and FADD was done in forty DLBCL cases. The association between MRP and apoptosis associated proteins to clinical findings was also tested. Results : Twenty-nine patients out of 40 (73%) with DLBCL were positive for Gp, and 26 cases (65%) had a strong positive for Gp. Gp expression was stronger in high-grade lesions than in low-grade lesions and was associated to Bcl-2 expression. However, we could not find an adverse impact of Gp expression on patients’ overall survival or relapse free survival rate. Conclusions : Our study revealed a high frequency of expression for Gp in DLBCL with a possible relationship between the expressions of Gp to apoptosis associated proteins.
Abstract
Background : Diffuse large B-cell lymphoma (DLBCL) is the most common type of malignant lymphoma which responds well to conventional chemotherapy. However, quite a few patients have a recurrence with more aggressive forms after completion of therapy. Multidrug resistance proteins (MRP) are related to this process in several ways such as cell cycle alteration and modulation of apoptosis. Methods : We investigated the expression of P-glycoprotein (Gp), one of the well-known MRP, as well as apoptosis associated proteins in DLBCL. Immunohistochemical staining for Gp, p53, Bcl-2, Ki-67, active caspase 3 and FADD was done in forty DLBCL cases. The association between MRP and apoptosis associated proteins to clinical findings was also tested. Results : Twenty-nine patients out of 40 (73%) with DLBCL were positive for Gp, and 26 cases (65%) had a strong positive for Gp. Gp expression was stronger in high-grade lesions than in low-grade lesions and was associated to Bcl-2 expression. However, we could not find an adverse impact of Gp expression on patients’ overall survival or relapse free survival rate. Conclusions : Our study revealed a high frequency of expression for Gp in DLBCL with a possible relationship between the expressions of Gp to apoptosis associated proteins.
참고문헌 (16)
- Csomor J, "Prolonged survival using anti-CD20 combined chemotherapy in primary prostatic intravascular large B-cell lymphoma", Pathol Oncol Res, 14, pp.281~284 (2008)
- Kahl B, "Chemotherapy combinations with monoclonal antibodies in non-Hodgkin’s lymphoma", Semin Hematol, 45, pp.90~94 (2008)
- Bessho Y, "ABCC10", MRP7 is associated with vinorelbine resistance in non-small cell lung cancer, 2009, pp.21, 263~268
- Fedasenka UU, "Expression of MDR1, LRP, BCRP and Bcl-2 genes at diagnosis of childhood all:comparison with MRD status after induction therapy", Exp Oncol, 30, pp.248~252 (2008)
- Larbcharoensub N, "Association between multidrug resistance-associated protein 1 and poor prognosis in patients with nasopharyngeal carcinoma treated with radiotherapy and concurrent chemotherapy", Hum Pathol, 39, pp.837~845 (2008)
- Pathology and genetics of tumours of haematopoietic and lymphoid tissues, "Jaffe E", IARC, ~ (2001)
- Maeshima AM, "Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma:morphological, immunohistochemical, and FISH analyses", Cancer Sci, 99, pp.1760~1768 (2008)
- Ohsawa M, "Immunohistochemical expression of multidrug resistance proteins as a predictor of poor response to chemotherapy and prognosis in patients with nodal diffuse large B-cell lymphoma", Oncology, 68, pp.422~431 (2005)
- Sharom FJ, "ABC multidrug transporters: structure, function and role in chemoresistance", Pharmacogenomics, 9, pp.105~127 (2008)
- Shman TV, "CD34+ leukemic subpopulation predominantly displays lower spontaneous apoptosis and has higher expression levels of Bcl-2 and MDR1 genes than CD34- cells in childhood AML", Ann Hematol, 87, pp.353~360 (2008)
- Johnstone RW, "Multiple physiological functions for multidrug transporter P-glycoprotein?", Trends Biochem Sci, 25, pp.1~6 (2000)
- Azab SS, "2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells?", Breast Cancer Res Treat, 113, pp.9~19 (2009)
- Fantappie O, "P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines", Cancer Res, 67, pp.4915~4923 (2007)
- Sakaeda T, "MDR1 up-regulated by apoptotic stimuli suppresses apoptotic signaling", Pharm Res, 19, pp.1323~1329 (2002)
- Germann UA, "Molecular analysis of the multidrug transporter, P-glycoprotein", Cytotechnology, 27, pp.31~60 (1998)
- Swerts K, "Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia", Eur J Cancer, 42, pp.295~309 (2006)